{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:26:15Z","timestamp":1793060775550,"version":"4.5.0"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2026,3,1]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Opioid withdrawal involves sympathetic hyperactivity and reduced parasympathetic tone, which standard pharmacological treatments may not adequately address, contributing to relapse vulnerability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate yoga as adjuvant therapy to accelerate opioid withdrawal recovery and assess its impact on heart rate variability, anxiety, sleep, and pain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This 2-arm, early-stage randomized clinical trial was conducted at an addiction medicine inpatient ward in India from April 30, 2023 to March 31, 2024. The outcome assessors and data analyst were blinded to group allocation. Participants included adults aged 18 to 50 years with opioid use disorder experiencing mild to moderate withdrawal symptoms (Clinical Opiate Withdrawal Scale [COWS] scores 4-24). Exclusion criteria included severe withdrawal, neurological conditions affecting autonomic function, severe psychiatric conditions, and recent yoga training. Of 68 individuals screened, 59 were randomized (30 yoga and 29 control participants).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>Participants in the yoga group received 10 supervised 45-minute sessions during 14 days alongside standard buprenorphine treatment, including relaxation practices, postures, breathing techniques, and guided relaxation. Participants in the control group received standard buprenorphine treatment only.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Co\u2013primary outcomes included time to withdrawal stabilization (COWS score &amp;amp;lt;4) and heart rate variability parameters. Secondary outcomes included anxiety (Hamilton Anxiety Rating Scale), sleep latency, and pain scores. Assessments were conducted at baseline (day 1) and day 15.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fifty-nine participants (59 male [100%]; mean [SD] age, 25.6 [3.9] years) completed intent-to-treat analysis. Participants in the yoga group recovered faster than those in the control group (hazard ratio [HR], 4.40; 95% CI, 2.40-8.07;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), with a median stabilization time of 5 days (95% CI, 4-6 days) for those in the yoga group vs 9 days (95% CI, 7-13 days) for the control group. Participants in the yoga group showed superior heart rate variability improvements with large effects on low frequency (LF) power (\u03c9\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090.16), high frequency (HF) power (\u03c9\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090.14), and LF\/HF ratio (\u03c9\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090.12); all effects were statistically significant (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). Mediation analysis showed that increases in parasympathetic activity accounted for 23% of the treatment effect (indirect HR, 1.38; 95% CI, 1.10-2.03). Anxiety reduction was significantly greater among those in the yoga group (\u03c9\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090.28;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), with moderate improvements in sleep latency (a 61-minute reduction;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.008) and pain (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.004).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this randomized clinical trial, yoga significantly accelerated opioid withdrawal recovery and improved autonomic regulation, anxiety, sleep, and pain. These findings support integrating yoga into withdrawal protocols as a neurobiologically informed intervention addressing core regulatory processes beyond symptom management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      Clinical Trials Registry of India Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/ctri.nic.in\/Clinicaltrials\/pmaindet2.php?EncHid=ODI5NTY=&amp;amp;amp;Enc=&amp;amp;amp;userName=\">CTRI\/2023\/04\/051302<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamapsychiatry.2025.3863","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T16:31:07Z","timestamp":1767803467000},"page":"238","source":"Crossref","is-referenced-by-count":5,"title":["Yoga for Opioid Withdrawal and Autonomic Regulation"],"prefix":"10.1001","volume":"83","author":[{"given":"Suddala","family":"Goutham","sequence":"first","affiliation":[{"name":"Department of Integrative Medicine, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant","family":"Bhargav","sequence":"additional","affiliation":[{"name":"Department of Integrative Medicine, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharath","family":"Holla","sequence":"additional","affiliation":[{"name":"Department of Integrative Medicine, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayant","family":"Mahadevan","sequence":"additional","affiliation":[{"name":"Centre for Addiction Medicine, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra P.","family":"Nagendra","sequence":"additional","affiliation":[{"name":"Centre for Consciousness Studies, Department of Neurophysiology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishitha","family":"Jasti","sequence":"additional","affiliation":[{"name":"Department of Integrative Medicine, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata Lakshmi","family":"Narasimha","sequence":"additional","affiliation":[{"name":"Centre for Addiction Medicine, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urvakhsh Meherwan","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivarama","family":"Varambally","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesan","family":"Venkatasubramanian","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhat","family":"Chand","sequence":"additional","affiliation":[{"name":"Centre for Addiction Medicine, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangalore Nanjundiah","family":"Gangadhar","sequence":"additional","affiliation":[{"name":"Department of Integrative Medicine, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin P.","family":"Hill","sequence":"additional","affiliation":[{"name":"Division of Addiction Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matcheri","family":"Keshavan","sequence":"additional","affiliation":[{"name":"Beth Israel Deaconess Medical Center and Massachusetts Mental Health Center, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratima","family":"Murthy","sequence":"additional","affiliation":[{"name":"Centre for Addiction Medicine, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India"},{"name":"Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"yoi250067r2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-019-0137-5","article-title":"Opioid use disorder.","volume":"6","author":"Strang","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"yoi250067r3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/ajad.12862","article-title":"Review article: effective management of opioid withdrawal symptoms: a gateway to opioid dependence treatment.","volume":"28","author":"Kosten","year":"2019","journal-title":"Am J Addict"},{"key":"yoi250067r5","doi-asserted-by":"publisher","first-page":"ii43","DOI":"10.1093\/pubmed\/fdab322","article-title":"Is there an opioid epidemic in India?","volume":"43","author":"Singh","year":"2021","journal-title":"J Public Health"},{"key":"yoi250067r6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2020.101978","article-title":"Tapentadol abuse and dependence in India.","volume":"49","author":"Mukherjee","year":"2020","journal-title":"Asian J Psychiatr"},{"issue":"1","key":"yoi250067r7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1151\/spp021113","article-title":"The neurobiology of opioid dependence: implications for treatment.","volume":"1","author":"Kosten","year":"2002","journal-title":"Sci Pract Perspect"},{"issue":"5","key":"yoi250067r8","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/jcpt.13114","article-title":"Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: current understanding and approaches to management.","volume":"45","author":"Pergolizzi","year":"2020","journal-title":"J Clin Pharm Ther"},{"issue":"2","key":"yoi250067r9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1177\/10783903221145142","article-title":"Heart rate variability in adults with substance use disorder: a comprehensive narrative review.","volume":"30","author":"Moon","year":"2024","journal-title":"J Am Psychiatr Nurses Assoc"},{"issue":"6","key":"yoi250067r10","doi-asserted-by":"publisher","DOI":"10.1111\/adb.13230","article-title":"Association between opioid use disorder and blunted heart rate variability among opioid-treated chronic pain patients.","volume":"27","author":"Roberts","year":"2022","journal-title":"Addict Biol"},{"issue":"1","key":"yoi250067r11","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.pnpbp.2012.01.006","article-title":"Cardiac autonomic modulation during methadone therapy among heroin users: a pilot study.","volume":"37","author":"Chang","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"yoi250067r12","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.06.040","article-title":"Changes in cardiac vagal tone as measured by heart rate variability during naloxone-induced opioid withdrawal.","volume":"204","author":"Levin","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"yoi250067r13","doi-asserted-by":"publisher","DOI":"10.1177\/02537176241292590","article-title":"Heart rate variability for supplementing withdrawal assessment in patients with opioid dependence: an exploratory study.","author":"Sarkar","year":"2024","journal-title":"Indian J Psychol Med"},{"issue":"6","key":"yoi250067r14","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1037\/amp0000638","article-title":"Mindfulness-oriented recovery enhancement reduces opioid dose in primary care by strengthening autonomic regulation during meditation.","volume":"75","author":"Garland","year":"2020","journal-title":"Am Psychol"},{"issue":"5","key":"yoi250067r15","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/00006842-200009000-00007","article-title":"Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease.","volume":"62","author":"Carney","year":"2000","journal-title":"Psychosom Med"},{"issue":"1-2","key":"yoi250067r16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1080\/09540261.2020.1761087","article-title":"Yoga and psychiatric disorders: a review of biomarker evidence.","volume":"33","author":"Bhargav","year":"2021","journal-title":"Int Rev Psychiatry"},{"issue":"11","key":"yoi250067r17","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3390\/jcm7110404","article-title":"Effects of mind-body exercises (Tai Chi\/Yoga) on heart rate variability parameters and perceived stress: a systematic review with meta-analysis of randomized controlled trials.","volume":"7","author":"Zou","year":"2018","journal-title":"J Clin Med"},{"issue":"3","key":"yoi250067r18","first-page":"20","article-title":"Development, validation, and feasibility testing of a yoga module for opioid use disorder.","volume":"35","author":"Bhargav","year":"2021","journal-title":"Adv Mind Body Med"},{"issue":"3","key":"yoi250067r19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1177\/17407745231212190","article-title":"Leveraging the functionality of Research Electronic Data Capture (REDCap) to enhance data collection and quality in the Opioid Analgesic Reduction Study.","volume":"21","author":"Fredericks-Younger","year":"2024","journal-title":"Clin Trials"},{"issue":"1","key":"yoi250067r20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0165-0327(88)90072-9","article-title":"The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders.","volume":"14","author":"Maier","year":"1988","journal-title":"J Affect Disord"},{"issue":"5","key":"yoi250067r21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/00002508-200409000-00005","article-title":"Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain.","volume":"20","author":"Keller","year":"2004","journal-title":"Clin J Pain"},{"issue":"5","key":"yoi250067r22","doi-asserted-by":"publisher","DOI":"10.1111\/anec.12565","article-title":"Ultra-short heart rate variability recording reliability: the effect of controlled paced breathing.","volume":"23","author":"Melo","year":"2018","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"3","key":"yoi250067r23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1620\/tjem.233.155","article-title":"Consciously controlled breathing decreases the high-frequency component of heart rate variability by inhibiting cardiac parasympathetic nerve activity.","volume":"233","author":"Sasaki","year":"2014","journal-title":"Tohoku J Exp Med"},{"issue":"2","key":"yoi250067r24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12160-009-9101-z","article-title":"Heart rate variability, prefrontal neural function, and cognitive performance: the neurovisceral integration perspective on self-regulation, adaptation, and health.","volume":"37","author":"Thayer","year":"2009","journal-title":"Ann Behav Med"},{"issue":"2","key":"yoi250067r25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4103\/0973-6131.205518","article-title":"Heart rate variability changes during and after the practice of Bhramari pranayama.","volume":"10","author":"Nivethitha","year":"2017","journal-title":"Int J Yoga"},{"issue":"11","key":"yoi250067r26","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.6026\/9732063002001549","article-title":"Effect of Bhastrika Pranayama on neuro- cardiovascular-respiratory function among yoga practitioners.","volume":"20","author":"Malhotra","year":"2024","journal-title":"Bioinformation"},{"key":"yoi250067r27","doi-asserted-by":"publisher","DOI":"10.1177\/09727531251318810","article-title":"An exploratory randomised trial to assess the effect of Nadi Shodhan Pranayama as an adjunct versus standard non-pharmacological management in hypertensives.","author":"Mittal","year":"2025","journal-title":"Ann Neurosci"},{"issue":"1","key":"yoi250067r28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4103\/ijoy.ijoy_141_21","article-title":"Immediate effects of OM chanting on heart rate variability measures compared between experienced and inexperienced yoga practitioners.","volume":"15","author":"Inbaraj","year":"2022","journal-title":"Int J Yoga"},{"issue":"3","key":"yoi250067r29","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.mehy.2006.02.042","article-title":"Physiology of long pranayamic breathing: neural respiratory elements may provide a mechanism that explains how slow deep breathing shifts the autonomic nervous system.","volume":"67","author":"Jerath","year":"2006","journal-title":"Med Hypotheses"},{"issue":"2","key":"yoi250067r31","doi-asserted-by":"publisher","first-page":"256","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_794_24","article-title":"Tapentadol as a drug of abuse\u2014a preliminary report.","volume":"67","author":"Shivaprakash","year":"2025","journal-title":"Indian J Psychiatry"},{"issue":"1","key":"yoi250067r32","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1176\/ajp.136.1.100","article-title":"Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal.","volume":"136","author":"Gold","year":"1979","journal-title":"Am J Psychiatry"},{"key":"yoi250067r1","volume-title":"World Drug Report 2024 (Set of 3 Booklets)","author":"United Nations Office on Drugs and Labor","year":"2025"},{"key":"yoi250067r4","volume-title":"Magnitude of Substance Use in India","author":"Ambekar","year":"2019"},{"key":"yoi250067r30","author":"Rao","year":"2014"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2843424\/jamapsychiatry_goutham_2026_oi_250067_1772546839.18631.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:00:22Z","timestamp":1772640022000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2843424"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2025.3863","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,1]]}}}